Kissei Pharmaceutical Co Financial Overview
Kissei Pharmaceutical Co's market cap is currently $1.18B. The company's EPS TTM is $0.5067306; its P/E ratio is 12.56; and it has a dividend yield of 2.74%. Kissei Pharmaceutical Co is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.
